Bryan Dulhunty

Analytica Ltd. engages in the design development, and supply of class 1 and class 2 medical devices. It operates through the following segment: Medical Devices and Corporate. The Medical Devices segment is consist of AutoStart Burette, PeriCoach, and ELF 2. The Corporate segment includes all other operations including the administration, and associated listed public company expenditure. The company is headquartered in Brisbane, Australia.

Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia.

1300 Smiles Ltd. owns and operates full-service dental facilities in Australia. Its services include dental surgeries, practice management and other services to self employed dentists who carry on their own dental practices. The firm provides comprehensive services in the areas of marketing, administration, billing and collections and facilities certification and licensing to all participating dentists. It also offers all support staff, equipment and facilities and sources all consumable goods using the buying power which derives from such a large group of dental businesses. The company was founded by Daryl Shane Holmes on September 18, 2000 and is headquartered in Townsville, Australia.

Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia.